BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
95 hedge funds and large institutions have $177M invested in BioSpecifics Technologies Corp. in 2015 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 24 reducing their positions, and 7 closing their positions.
143% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 7
50% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 24
19% more capital invested
Capital invested by funds: $148M → $177M (+$28.6M)
10% more funds holding
Funds holding: 86 → 95 (+9)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$3.04M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$2.98M |
| 3 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
+$2.9M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.06M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$1.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$2.42M |
| 2 |
Morgan Stanley
New York
|
-$1.78M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$1.31M |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$1.27M |
| 5 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$913K |
BSTC Hedge Fund Activity: Q4 2015 in Review
95 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2015, worth a combined $177M — up 19% from $148M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new BSTC positions and 7 closed out — a net gain of 10 holders — while 36 added to existing stakes and 24 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $3.04M. The largest seller was Bogle Investment Management, exiting entirely with an estimated $2.42M sold.
- 95 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q4 2015, up from 86 in Q3 2015.
- Funds reported $177M of BioSpecifics Technologies Corp. stock for Q4 2015, up 19% quarter-over-quarter.
- 17 funds opened new BioSpecifics Technologies Corp. positions in Q4 2015 and 7 closed out, a net change of +10 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q4 2015 was Renaissance Technologies, an estimated $3.04M added.
- The largest BioSpecifics Technologies Corp. seller in Q4 2015 was Bogle Investment Management, an estimated $2.42M sold.
Based on aggregated 13F filings for Q4 2015.